Clinical trial

Treatment of Failing Blebs With Ranibizumab

NCT00570726

Study summary

ClinicalTrials.gov

Treatment of Failing Blebs With Ranibizumab

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Ranibizumab (Lucentis) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-06-01

PhasePHASE1

Conditions

Glaucoma, Open-Angleunresolved

Failing Bleb Following Trabeculectomyunresolved

Interventions

Ranibizumab (Lucentis)DRUG

Sponsors & collaborators

The New York Eye & Ear Infirmarylead sponsor

Genentech, Inc.collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00570726 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.